« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 2
, Pages 152-159
, February 2006
Skin Explant Model of Human Graft-versus-Host Disease: Prediction of Clinical Outcome and Correlation with Biological Risk Factors
References
- Host specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings . N Engl J Med . 1992;327:1613–1617
- Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantation . Blood . 1993;82:2216–2223
- . Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation . Blood . 2001;98:1594–1600
- . Donor CD31 genotype impacts on transplant complications after human leukocyte antigen-matched sibling allogeneic bone marrow transplantation . Transplantation . 2005;79:602–605
- Increase of interleukin-18 serum levels after engraftment correlates with acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation . J Cancer Res Clin Oncol . 2004;130:704–710
- Prediction of acute graft-versus-host disease and detection of distinct end-organ targets by enumeration of peripheral blood cytokine spot-forming cells . Transplantation . 2005;80:58–65
- An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants . N Engl J Med . 1985;313:645–650
- Predicting graft-versus-host disease in HLA-identical bone marrow transplants (a comparison of T cell frequency analysis and a human skin explant model) . Transplantation . 1998;66:857–863
- . A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation . J Clin Pathol . 1999;52:910–913
- . Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model . Bone Marrow Transplant . 1991;7:209–216
- In situ dissection of graft-versus-host and graft-versus-leukemia effects by minor histocompatibility antigen specific cytotoxic T cells . Nat Med . 2002;8:410–414
- Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients . Bone Marrow Transplant . 1994;13:65–70
- IL-10 modulation of alloreactivity and graft-versus-host-reactions . Transplantation . 2002;74:772–778
- Graft-versus-host disease of the skin (life and death on the epidermal edge) . Biol Blood Marrow Transplant . 2004;10:366–372
- Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors . Transplantation . 1974;18:295–304
- Graft-versus-host disease after nonmyeloablative versus conventional haematopoietic stem cell transplantation . Blood . 2003;102:756–762
- Skin explant culture as a model for cutaneous graft-versus-host disease in humans . Bone Marrow Transplant . 1988;3:323–329
- . An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients . Bone Marrow Transplant . 1990;5:105–109
- . Histopathology of graft-vs-host reaction (GvHR) in human recipients of marrow from HLA-matched sibling donors . Transplant Proc . 1974;6:367–371
- . Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA matched, related haematopoietic stem cell transplants . Blood . 2004;103:347–352
- Acute graft-versus-host disease (analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate) . Blood . 1992;80:1838–1845
- Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years . Blood . 2003;102:3052–3059
- Hematopoietic stem cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies (older age is no longer a contraindication when using reduced intensity conditioning) . Leukemia . 2005;19:7–12
- . Prognostic factor for long-term survival in leukaemia marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease . Clin Transplant . 1994;8:258–270
- Use of a skin explant model for predicting GVHD in HLA-matched bone marrow transplants—effect of GVHD prophylaxis . Bone Marrow Transplant . 1999;24:857–863
- In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors . Bone Marrow Transplant . 2002;29:683–689
- In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation . Blood . 2000;96:2419–2425
- Cellular alloreactivity of human cord blood cells detected by T cell frequency analysis and a human skin explant model . Transplantation . 1998;66:903–909
- Bone marrow transplantation in patients aged 45 years and older . Blood . 1986;67:770–776
- Age and immune response in organ transplantation . Transplantation . 2005;79:127–132
PII: S1083-8791(05)00671-3
doi: 10.1016/j.bbmt.2005.09.018
© 2006 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 12, Issue 2
, Pages 152-159
, February 2006
